 25 PM / in 9 minutes BRIEF-Akcea Initiates Phase 2b Study Of Hypertriglyceridemia And Established Heart Disease Treatment Reuters Staff 
Jan 5 (Reuters) - Akcea Therapeutics Inc: 
* AKCEA INITIATES PHASE 2B STUDY OF AKCEA-APOCIII-LRX IN PATIENTS WITH HYPERTRIGLYCERIDEMIA AND ESTABLISHED CARDIOVASCULAR DISEASE 
* AKCEA THERAPEUTICS INC - ‍ ANTICIPATES REPORTING TOP-LINE DATA FROM PHASE 2B OF AKCEA-APOCIII-L(RX)​ STUDY IN 2019 Source text for Eikon: Further company coverage: